Steven R. Pollard, Ph.D.

Dr. Pollard received his B.S. from the University of Tennessee at Chattanooga, his M.S. from Florida International University, and his Ph.D. Florida International University. Dr. Pollard began his career at Seabreeze Behavioral Medicine and Gulf Coast Health Services, before joining the Peace River Psychology Center team in 2001. 

​

Dr. Pollard's primary focus is neuropsychological assessment. In addition to currently conducting neuropsychological assessments at Peace River Psychology, he has served as sub-investigator and neuropsychological consultant on multiple pharmaceutical drug trials including Aricept, Exelon, Galantamine, Risperdal, and Abilify. 

​

Dr. Pollard has over 25 years of experience in conducting neuropsychological assessments pursuant to diagnostic corroboration on the following conditions:

​

Neurocognitive disorders due to:

• Alzheimer’s disease

• Cerebrovascular disease

• Frontotemporal lobar degeneration

• Infectious Processes, e.g. HIV/AIDS, Lyme disease

• Parkinson’s disease

• Atypical Parkinsonisms, including 

  • Lewy body disease

  • Progressive Supranuclear Palsy 

  • Multi-System Atrophy 

  • Cortico-Basal Degeneration

  • Medication/Substance-induced Parkinsonism

  • Progressive CNS disorders, e.g. Multiple Sclerosis

  • Toxin Exposure 

  • Traumatic Brain Injury

  • Toxin Exposure

  • Tardive Dyskinesia

​

Differential Diagnoses, including:

• Mild versus Major Neurocognitive Disorder (NCD)

• Delirium versus Dementia/Major NCD

• Pseudodementia versus Dementia/Major NCD

• Dementia/Major NCD versus Somatic Symptom and related disorders 

• Dementia/Major NCD versus Malingering